RGEN

REPLIGEN CORP

Healthcare | Mid Cap

$0.49

EPS Forecast

$197

Revenue Forecast

Announcing earnings for the quarter ending 2025-12-31T00:00:00 soon
DNLIDenali Therapeutics IncNVAXNovavax IncNBIXNeurocrine Biosciences IncTECHBio-techne CorpCRSPCrispr Therapeutics AgMRNAModerna IncHALOHalozyme Therapeutics IncIOVAIovance Biotherapeutics IncREPLReplimune Group Inc